Literature DB >> 9533192

Three-year changes in cognitive performance as a function of apolipoprotein E genotype: evidence from very old adults without dementia.

B J Small1, H Basun, L Bäckman.   

Abstract

This study examined whether baseline cognitive performance and 3-year longitudinal changes were influenced by apolipoprotein E epsilon 4 (APOE-epsilon 4) allele. Participants consisted of 20 APOE-epsilon 4 (2 epsilon 2/epsilon 4; 17 epsilon 3/epsilon 4; 1 epsilon 4/epsilon 4) and 54 non-epsilon 4 (12 epsilon 2/epsilon 3; 42 epsilon 3/epsilon 3) very old adults without dementia (M = 81.82 +/- 5.06 years) participating in a population-based longitudinal study. Cognitive performance was indexed by the Mini-Mental State Examination and multiple indexes of memory, visuospatial, and verbal performance. The results indicated no significant baseline differences between the 2 APOE groups in any cognitive performance measure. However, analyses revealed that the APOE-epsilon 4 group experienced greater negative change in recognition memory for faces and words. Changes in tasks assessing other abilities did not vary as a function of APOE status. The authors concluded that APOE-epsilon 4 status may not influence cognitive performance in adults without dementia and speculated that when such effects do occur (e.g., decline in recognition memory), these may be related to impending dementia, rather than to the influence of the specific genotype on cognition in normal aging.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9533192     DOI: 10.1037//0882-7974.13.1.80

Source DB:  PubMed          Journal:  Psychol Aging        ISSN: 0882-7974


  16 in total

1.  Genetics and visual attention: selective deficits in healthy adult carriers of the epsilon 4 allele of the apolipoprotein E gene.

Authors:  P M Greenwood; T Sunderland; J L Friz; R Parasuraman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

Review 2.  Neuropsychological and neuroimaging changes in preclinical Alzheimer's disease.

Authors:  Elizabeth W Twamley; Susan A Legendre Ropacki; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2006-09       Impact factor: 2.892

3.  Decline in verbal memory during preclinical Alzheimer's disease: examination of the effect of APOE genotype.

Authors:  Kelly L Lange; Mark W Bondi; David P Salmon; Douglas Galasko; Dean C Delis; Ronald G Thomas; Leon J Thal
Journal:  J Int Neuropsychol Soc       Date:  2002-11       Impact factor: 2.892

4.  Age-related differences in memory and executive functions in healthy APOE ɛ4 carriers: the contribution of individual differences in prefrontal volumes and systolic blood pressure.

Authors:  Andrew R Bender; Naftali Raz
Journal:  Neuropsychologia       Date:  2012-01-10       Impact factor: 3.139

5.  Abnormal event-related potentials in young and middle-aged adults with the ApoE ε4 allele.

Authors:  Krystin Corby; Charlie D Morgan; Claire Murphy
Journal:  Int J Psychophysiol       Date:  2011-11-18       Impact factor: 2.997

6.  Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study.

Authors:  Kathleen M Hayden; Peter P Zandi; Nancy A West; Joann T Tschanz; Maria C Norton; Chris Corcoran; John C S Breitner; Kathleen A Welsh-Bohmer
Journal:  Arch Neurol       Date:  2009-11

7.  Homocysteine lowering and cognition in CKD: the Veterans Affairs homocysteine study.

Authors:  Christopher B Brady; J Michael Gaziano; Roberta A Cxypoliski; Peter D Guarino; James S Kaufman; Stuart R Warren; Pamela Hartigan; David S Goldfarb; Rex L Jamison
Journal:  Am J Kidney Dis       Date:  2009-07-23       Impact factor: 8.860

8.  Age and apolipoprotein E genotype influence rate of cognitive decline in nondemented elderly.

Authors:  David P Salmon; Steven H Ferris; Ronald G Thomas; Mary Sano; Jeffery L Cummings; Reisa A Sperling; Ronald C Petersen; Paul S Aisen
Journal:  Neuropsychology       Date:  2013-07       Impact factor: 3.295

9.  Apolipoprotein E and cholesterol in aging and disease in the brain.

Authors:  Elena Posse de Chaves; Vasanthy Narayanaswami
Journal:  Future Lipidol       Date:  2008-10

10.  Olfaction in aging and Alzheimer's disease: event-related potentials to a cross-modal odor-recognition memory task discriminate ApoE epsilon4+ and ApoE epsilon 4- individuals.

Authors:  Claire Murphy; Ethan S Solomon; Lori Haase; Miran Wang; Charlie D Morgan
Journal:  Ann N Y Acad Sci       Date:  2009-07       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.